BioCentury
ARTICLE | Company News

Former Insys CEO pleads guilty to opioid prescription kickbacks

January 11, 2019 6:30 PM UTC

Michael Babich, former president and CEO of Insys Therapeutics Inc. (NASDAQ:INSY), pleaded guilty on Jan. 9 in conspiring to bribe physicians to unnecessarily prescribe Subsys fentanyl sublingual spray and defraud insurance companies.

The opioid is approved in the U.S. to treat breakthrough cancer pain...

BCIQ Company Profiles

Insys Therapeutics Inc.